Access cutting-edge advanced cancer treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access advanced cancer specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced cancer treatment provided free
BIPAVE-001 is a Phase 1-2 study for evaluating the safety, pharmacokinetics (PK), and efficacy of AI-081 in solid tumors.
Sponsor: OncoC4, Inc.
Check if you qualify for this advanced cancer clinical trial in Chicago, IL
If you're searching for advanced cancer treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.